Human Immunology News 4.35 September 6, 2016 | |
| |
TOP STORYInvestigators showed that, in humans and in mice, innate intestinal intraepithelial lymphocytes expressing intracellular CD3 differentiate along an Id2 transcription factor (TF)-independent pathway in response to TF NOTCH1, interleukin-15, and Granzyme B signals. [Immunity] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)When the mucin MUC1 is expressed on cancer cells, it is decorated by multiple short, sialylated O-linked glycans. Investigators found that this cancer-specific MUC1 glycoform, through engagement of Siglec-9, ‘educated’ myeloid cells to release factors associated with determination of the tumor microenvironment and disease progression. [Nat Immunol] Abstract iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy Adipose-resident invariant natural killer T (iNKT) cell activation induced fibroblast growth factor 21 (FGF21) production and thermogenic browning of white fat. Complete metabolic analysis revealed that iNKT cell activation induced increased body temperature, V02, VC02, and fatty acid oxidation, without affecting food intake or activity. [Cell Metab] Abstract | Graphical Abstract Regulation of Monocyte Cell Fate by Blood Vessels Mediated by Notch Signaling A population of monocytes, known as Ly6Clo monocytes, patrol blood vessels by crawling along the vascular endothelium. Researchers showed that endothelial cells control their origin through Notch signaling. [Nat Commun] Full Article Although studies have demonstrated that tumor-derived cytokines promote myeloid-derived suppressor cell (MDSC) accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation. The authors identified a novel mechanism of MDSC differentiation. [Oncogene] Abstract Distinct Microenvironmental Cues Stimulate Divergent TLR4-Mediated Signaling Pathways in Macrophages The microbial product lipopolysaccharide and the extracellular matrix glycoprotein tenascin-C are released during bacterial infection and tissue injury, respectively, and both activate Toll-like receptor 4 (TLR4). Investigators found that these two TLR4 ligands stimulated distinct signaling pathways in macrophages, resulting in cells with divergent phenotypes. [Sci Signal] Abstract Scientists used a three-dimensional flowing microfluidic chip to screen the effective candidate against monosodium urate-stimulated human umbilical vein endothelial cell damage, and found kinsenoside to be the leading active component of Anoectochilus roxburghi, one of the Chinese medicinal plants widely used in the treatment of gouty arthritis clinically. [Cell Death Dis] Full Article Differential expression of cell surface receptors may result in altered thresholds of neonatal immune cell activation. The authors determined whether the expression and function of the lipid-binding CD300 family of receptors are different on neonatal immune cells compared to adult immune cells. [Sci Rep] Full Article Scientists investigated the phenotypes and immune response of mucosal-associated invariant T (MAIT) cells from tuberculous pleural effusions and peripheral blood. [Sci Rep] Full Article Subscribe to our sister publications: Immunology of Infectious Disease News & Immune Regulation News. | |
| |
REVIEWSAcute Severe Ulcerative Colitis: From Pathophysiology to Clinical Management Ulcerative colitis is a common chronic inflammatory disease of the colon and rectum, resulting from a dysregulated immune response towards intraluminal antigens in a genetically predisposed host. The disease has a varying extent and severity. [Nat Rev Gastroenterol Hepatol] Abstract What Rheumatologists Need to Know About Innate Lymphocytes The authors summarize the main characteristics and functions of innate lymphocyte subsets, and describe their roles in autoimmune disease. They also discuss how biological therapies influence innate lymphocyte function and consider the potential for these cell subsets to act as future therapeutic targets. [Nat Rev Rheumatol] Abstract Visit our reviews page to see a complete list of reviews in the human immunology research field. | |
| |
INDUSTRY NEWSSoligenix Announces Issuance of New Composition of Matter Patent for Dusquetide Analogs Soligenix, Inc. announced that the United States Patent Office granted the patent entitled “Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity.” The newly issued patent claims composition of matter of analogs of dusquetide, the company’s lead development compound. [Soligenix, Inc.] Press Release Rigel’s Fostamatinib Meets Primary Endpoint in Phase III Study in Chronic ITP Rigel Pharmaceuticals, Inc. announced that fostamatinib, its oral spleen tyrosine kinase inhibitor, met the primary endpoint in the first of two double-blind studies in the FIT Phase III clinical program for the treatment of adult chronic/persistent immune thrombocytopenia (ITP). [Rigel Pharmaceuticals, Inc.] Press Release Arena Pharmaceutics Announces Formation of Beacon Discovery Arena Pharmaceuticals, Inc. announced the formation of Beacon Discovery Inc. (“Beacon”), an independent, privately-held drug discovery incubator. Beacon will focus on identifying and advancing molecules targeting G-Protein Coupled Receptors from concept to clinic leveraging the strengths and capabilities developed over close to two decades at Arena. [Arena Pharmaceuticals, Inc.] Press Release | |
| |
POLICY NEWSCongress Returns, with a Long Science To-Do List and Not Much Time Congress returns from a 7-week summer break with a lengthy list of unfinished business, some of great interest to the U.S. research community—and just a few weeks to tackle it. [ScienceInsider] Editorial New Vaccine Coalition Aims to Ward Off Epidemics A new public-private coalition that aims to derail epidemics by speeding development of vaccines has now hung its shingle with the backing of the Wellcome Trust and the Bill & Melinda Gates Foundation. [ScienceInsider] Editorial Turkey Sacks Thousands of University Staff Turkey’s government has sacked 2,346 university staff for suspected ties to July’s attempted military coup in the country. The sackings, announced in a 1 September decree as part of a wider purge of 40,000 civil servants, are the first of an expected wave of dismissals under powers granted by state-of-emergency rules following the coup. [Nature News] Editorial
| |
EVENTSNEW 5th Australian College for Infection Prevention and Control (ACIPC) 2016 Conference NEW EMBO Conference: Innate Lymphoid Cells Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Faculty Positions – Various Areas (Jackson Laboratory) Technical Sales Representative (STEMCELL Technologies Inc.) Research Technologist – Cell Separation (STEMCELL Technologies Inc.) Senior Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.) Postdoctoral Researcher – Translational Immunology (University of Eastern Finland) Faculty Position – Immunology (Vanderbilt University Medical Center) Postdoctoral Fellow – Mucosal Immunology (University of Utah) Postdoctoral Fellow – Metastatic Breast Cancer (Purdue Center for Cancer Research) Assistant Associate – Cancer Immunology (Fred Hutchinson Cancer Research Center) Postdoctoral Research Associate – Immunology (Benaroya Research Institute at Virginia Mason) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Human Immunology News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Human Immunology News Volume 4.35 | Sep 6 2016